We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
General Dynamics (GD) NASSCO Wins Deal to Support DDG 91 Ships
Read MoreHide Full Article
General Dynamics Corp.’s (GD - Free Report) business unit, NASSCO, recently secured a $98.7-million contract for the modernization of the USS Pinckney (DDG 91) Arleigh Burke-class missile destroyer. The contract was awarded by the Naval Sea Systems Command, Washington, D.C.. Work related to the deal will be performed in San Diego, CA, and is scheduled to be completed by July 2023. If additional options of the contract are exercised by both parties, the entire value of the same could reach $121.1 million.
Growing Importance of DDG 91 Ships
Being one of the largest military shipbuilding manufacturers in the United States, General Dynamics enjoys a dominant position in the global naval shipbuilding market. The DDG 91 ships have gained widespread importance within the U.S. Naval forces, as these warships are equipped with Lockheed Martin’s (LMT - Free Report) Aegis Weapon System, a highly integrated naval weapon system. These missile destroyers also contain SH-60 Seahawk helicopters, and advanced anti-aircraft and land-attack missiles.
With growing demand for this warship, General Dynamics is witnessing a steady flow of contracts. Alongside General Dynamics, Huntington Ingalls (HII - Free Report) , the largest military shipbuilding company in the United States, manufactures the DDG 91 Arleigh Burke-Class destroyer ship for the U.S. Navy.
Notably, the DDG 91 Arleigh Burke-class missile destroyers’ importance continues to grow as these ships offer a wide range of advanced warfighting capabilities in multi-threat air, surface and subsurface environments. It also offers protection against a wide range of threats, including ballistic missiles.
Future Prospects
Per a report released by the U.S. Department of Defense, the fiscal 2022 defense budget includes a spending provision of $34.6 billion on combat-effective naval forces, higher than fiscal 2021’s allotted budget of $32.3 billion. The allotted budget specifically includes the requirement of one Arleigh Burke Destroyer. Such favorable budgetary projections bode well for major shipbuilders like General Dynamics, as it increases the company’s possibility of winning more shipbuilding and associated contracts.
Further, looking ahead, the global naval shipbuilding market is expected to grow by $14.36 billion during the 2020-2024 period at a CAGR of 3%, as estimated by a Technavio report. Notably, other players in the same industry, such as Mitsubishi Heavy Industries, Ltd. (MHVYF - Free Report) , alongside General Dynamics and Huntington Ingalls, should potentially benefit from the projected growth of the naval shipbuilding market.
Our View
General Dynamics has been serving the U.S. Navy by constructing and delivering next-generation combat ships for decades. Being one of the Navy's primary surface combatants, the DDG 91 destroyers enjoy solid demand. Such steep demand places General Dynamics at an advantageous position in the shipbuilding business.
Price Performance & Zacks Rank
Shares of General Dynamics have gained 15.3% in a year compared with the industry’s growth of 3.7%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
General Dynamics (GD) NASSCO Wins Deal to Support DDG 91 Ships
General Dynamics Corp.’s (GD - Free Report) business unit, NASSCO, recently secured a $98.7-million contract for the modernization of the USS Pinckney (DDG 91) Arleigh Burke-class missile destroyer. The contract was awarded by the Naval Sea Systems Command, Washington, D.C.. Work related to the deal will be performed in San Diego, CA, and is scheduled to be completed by July 2023. If additional options of the contract are exercised by both parties, the entire value of the same could reach $121.1 million.
Growing Importance of DDG 91 Ships
Being one of the largest military shipbuilding manufacturers in the United States, General Dynamics enjoys a dominant position in the global naval shipbuilding market. The DDG 91 ships have gained widespread importance within the U.S. Naval forces, as these warships are equipped with Lockheed Martin’s (LMT - Free Report) Aegis Weapon System, a highly integrated naval weapon system. These missile destroyers also contain SH-60 Seahawk helicopters, and advanced anti-aircraft and land-attack missiles.
With growing demand for this warship, General Dynamics is witnessing a steady flow of contracts. Alongside General Dynamics, Huntington Ingalls (HII - Free Report) , the largest military shipbuilding company in the United States, manufactures the DDG 91 Arleigh Burke-Class destroyer ship for the U.S. Navy.
Notably, the DDG 91 Arleigh Burke-class missile destroyers’ importance continues to grow as these ships offer a wide range of advanced warfighting capabilities in multi-threat air, surface and subsurface environments. It also offers protection against a wide range of threats, including ballistic missiles.
Future Prospects
Per a report released by the U.S. Department of Defense, the fiscal 2022 defense budget includes a spending provision of $34.6 billion on combat-effective naval forces, higher than fiscal 2021’s allotted budget of $32.3 billion. The allotted budget specifically includes the requirement of one Arleigh Burke Destroyer. Such favorable budgetary projections bode well for major shipbuilders like General Dynamics, as it increases the company’s possibility of winning more shipbuilding and associated contracts.
Further, looking ahead, the global naval shipbuilding market is expected to grow by $14.36 billion during the 2020-2024 period at a CAGR of 3%, as estimated by a Technavio report. Notably, other players in the same industry, such as Mitsubishi Heavy Industries, Ltd. (MHVYF - Free Report) , alongside General Dynamics and Huntington Ingalls, should potentially benefit from the projected growth of the naval shipbuilding market.
Our View
General Dynamics has been serving the U.S. Navy by constructing and delivering next-generation combat ships for decades. Being one of the Navy's primary surface combatants, the DDG 91 destroyers enjoy solid demand. Such steep demand places General Dynamics at an advantageous position in the shipbuilding business.
Price Performance & Zacks Rank
Shares of General Dynamics have gained 15.3% in a year compared with the industry’s growth of 3.7%.
General Dynamics currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>